Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.63 |
| ▸ | CA6 | P23280 | 5/20 | 0.63 |
| ▸ | CA7 | P43166 | 5/20 | 0.63 |
| ▸ | CA9 | Q16790 | 5/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.63 |
| ▸ | CA2 | P00918 | 4/20 | 0.63 |
| ▸ | CA4 | P22748 | 4/20 | 0.63 |
| ▸ | CA5A | P35218 | 4/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | CASP2 | P42575 | 2/20 | 0.63 |
| ▸ | F13A1 | P00488 | 2/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | THPO | P40225 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | RECQL | P46063 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | CA3 | P07451 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8261495 | 1.00 | CA12 (0.63) | CA12CA6CA7CA9CA14 | |
| SCHEMBL14457278 | 0.97 | CA12 (0.68) | CA12CA6CA7CA9CA14 | |
| SCHEMBL5418689 | 0.97 | CA12 (0.68) | CA12CA6CA7CA9CA14 | |
| SCHEMBL13663849 | 0.97 | CASP2 (0.68) | CA12CA6CA7CA9CA14 | |
| SCHEMBL16573359 | 0.95 | CA12 (0.65) | CA12CA6CA7CA9CA14 | |
| SCHEMBL5406821 | 0.94 | CA12 (0.72) | CA12CA6CA7CA9CA14 | |
| SCHEMBL343729 | 0.92 | CA12 (0.65) | CA12CA6CA7CA9CA14 | |
| SCHEMBL25239603 | 0.92 | CA12 (0.59) | CA12CA6CA7CA9CA14 | |
| SCHEMBL8309829 | 0.92 | — | — | |
| SCHEMBL22900821 | 0.90 | CA12 (0.62) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2473540-A1 | STRUCTURAL URETHANE ADHESIVES COMPRISING AMIDE POLYOLS | Ashland Licensing And Intellectual Property LLC (US) | 2012-07-11 | — | — | EP | claimed |
| WO-2011028586-A1 | STRUCTURAL URETHANE ADHESIVES COMPRISING AMIDE POLYOLS | ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC (US) | 2011-03-10 | — | — | WO | claimed |
| EP-4355803-A1 | POLYAMINES AS ALDEHYDE SCAVENGERS | BASF SE (DE) | 2024-04-24 | — | — | EP | disclosed |
| CN-117915958-A | Dendritic structures as non-viral vectors in gene delivery | 蒂巴生物技术有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20230174679-A1 | NITRIC OXIDE-RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS FABRICATED THEREFROM AND METHODS PERTAINING THERETO | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2023-06-08 | — | — | US | disclosed |
| US-20230174679-A1 | NITRIC OXIDE-RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS FABRICATED THEREFROM AND METHODS PERTAINING THERETO | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2023-06-08 | — | — | US | disclosed |
| WO-2023052002-A1 | TWO COMPONENT (2K) COMPOSITION BASED ON EPOXY (METH)ACRYLATE RESIN | HENKEL AG & CO. KGAA (DE) | 2023-04-06 | — | — | WO | disclosed |
| EP-4159784-A1 | TWO COMPONENT (2K) COMPOSITION BASED ON EPOXY (METH)ACRYLATE RESIN | Henkel AG & Co. KGaA (DE) | 2023-04-05 | — | — | EP | disclosed |
| WO-2022263229-A1 | POLYAMINES AS ALDEHYDE SCAVENGERS | BASF SE (DE) | 2022-12-22 | — | — | WO | disclosed |
| US-11421044-B2 | Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2022-08-23 | — | — | US | disclosed |
| US-20210371548-A1 | HYALURONIC ACID DERIVATIVE MODIFIED WITH POLYETHYLENE GLYCOL | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2021-12-02 | — | — | US | disclosed |
| US-7393827-B2 | Pharmaceutical compositions and methods for restoring β-cell mass and function | DIAKINE THERAPEUTICS, INC. (US) | 2008-07-01 | — | — | US | disclosed |
| WO-2008011518-A2 | ENCAPSULATION SYSTEM | DIAKINE THERAPEUTICS, INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| WO-2007146786-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR RESTORING B-CELL MASS AND FUNCTION | DIAKINE THERAPEUTICS, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2006074051-A2 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR RESTORING β-CELL MASS AND FUNCTION | DIAKINE THERAPEUTICS, INC. (US) | 2006-07-13 | — | — | WO | disclosed |
| EP-1465611-A2 | COMPOSITION, SYNTHESIS AND THERAPEUTIC APPLICATIONS OF POLYAMINES | Murphy, Michael A. (US) | 2004-10-13 | — | — | EP | disclosed |
| WO-2003051348-A2 | COMPOSITION, SYNTHESIS AND THERAPEUTIC APPLICATIONS OF POLYAMINES | MURPHY MICHAEL A (US) | 2003-06-26 | — | — | WO | disclosed |
| US-6479498-B1 | COMPRISE 2-10 SODIUM CHANNEL LIGANDS COVALENTLY CONNECTED BY A LINKER OR LINKERS | THERAVANCE, INC. | 2002-11-12 | — | — | US | disclosed |
| US-6420354-B1 | Sodium channel drugs and uses | ADVANCED MEDICINE, INC. | 2002-07-16 | — | — | US | disclosed |
| US-3992335-A | FILM FORMING MACROMOLECULE AND PLASTICIZER, ANHYDRIDROUS | AIRWICK INDUSTRIES, INC. (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174679-A1 | NITRIC OXIDE-RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS FABRICATED THEREFROM AND METHODS PERTAINING THERETO | NOS2, NOS3, NOS1 | CA12 3584/4885CA6 1006/4885CA7 1735/4885 |
| US-20210371548-A1 | HYALURONIC ACID DERIVATIVE MODIFIED WITH POLYETHYLENE GLYCOL | CD44, F12, HPSE | CA12 90/4885CA6 205/4885CA7 278/4885 |
| US-11421044-B2 | Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto | NOS2, NOS3, NOS1 | CA12 3584/4885CA6 1006/4885CA7 1735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.